1. Home
  2. GCTS vs XBIT Comparison

GCTS vs XBIT Comparison

Compare GCTS & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GCT Semiconductor Holding Inc.

GCTS

GCT Semiconductor Holding Inc.

HOLD

Current Price

$1.18

Market Cap

82.1M

Sector

Finance

ML Signal

HOLD

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.38

Market Cap

73.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GCTS
XBIT
Founded
1998
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Pharmaceuticals and Biotechnology
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.1M
73.2M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
GCTS
XBIT
Price
$1.18
$2.38
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$3.50
N/A
AVG Volume (30 Days)
210.0K
51.1K
Earning Date
11-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,893,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1,184.40
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.90
$2.09
52 Week High
$2.76
$4.67

Technical Indicators

Market Signals
Indicator
GCTS
XBIT
Relative Strength Index (RSI) 36.93 48.52
Support Level $1.12 $2.40
Resistance Level $1.27 $2.55
Average True Range (ATR) 0.10 0.09
MACD -0.01 -0.01
Stochastic Oscillator 17.14 36.36

Price Performance

Historical Comparison
GCTS
XBIT

About GCTS GCT Semiconductor Holding Inc.

GCT Semiconductor Holding Inc is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem, and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.

About XBIT XBiotech Inc.

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.

Share on Social Networks: